Patrick Barkaus, MD
Family Practice · Lynbrook, NYNPI 1982280848
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Novo Nordisk at 36.1% of the total. Among family practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $29.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$199
- AbbVie$168
- Sanofi$49
- Regeneron Healthcare Solutions, Inc.$46
- Lilly USA, LLC$45
- Astellas Pharma US Inc$26
- plus $19 from 1 others
What the payments were for
- Food & beverage$552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $199 |
| AbbVie | 8 | $168 |
| Sanofi | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| Astellas Pharma US Inc | 1 | $26 |
| Pfizer | 1 | $19 |
How this compares
$552 in reported general payments places this provider in the 95th percentile of 792 family practice providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $2,906 |
| Atorvastatin Calcium | 49 | $543 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $350 |
| Fluticasone Propionate | 17 | $240 |
| Levothyroxine Sodium | 17 | $234 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $131 |
| Losartan Potassium | 19 | $104 |
| Metoprolol Succinate | 11 | $98 |
| Metformin Hcl | 11 | $66 |
| Alprazolam | 13 | $56 |
| Azithromycin | 18 | $42 |
| Prednisone | 13 | $36 |
| Amlodipine Besylate | 13 | $25 |
| Warfarin Sodium | 17 | $22 |
Paid to pharmacies, not to this prescriber.
Other family practice in Lynbrook
- Benjamin WuBrooklyn$16K
- Carmen FamiliaBronx$11K
- Rosanne CebelenskiDeer Park$10K
- Sumathy ReddyIsland Park$4K
- Yagnasri EagalaNew Hartford$2K
- Kristen MerolaSyracuse$1K
- Kristen MailandEast Setauket$934
- Rashid GirshabUtica$923
- Esra Bayram FidanRiverhead$888
- Deborah CohenJohnson City$770
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.